Objective To assess the characteristics and quality of cost utility analyses (CUA) related to otolaryngology within the CEA registry and to summarize their collective results. Methods All cost-utility analyses published between 1976 and 2011 contained in the Cost-Effectiveness Analysis Registry (CEA Registry) were evaluated. Topics that fall within the care of an otolaryngologist were include...

Uncertainty and importance of CE evidence of health care interventions more generally, and of HIV/AIDS interventions in particular have been two main reasons put forward to justify the need for cost-effectiveness analysis (CEA) of such interventions. However, CEA focused more on HIV/AIDS interventions, characterized by different set of activities and less on contextual HIV/AIDS interventions (C...

Health care cost-effectiveness analysis (CEA) often uses individual patient data (IPD) from multinational randomized controlled trials. Although designed to account for between-patient sampling variability in the clinical and economic data, standard analytical approaches to CEA ignore the presence of between-location variability in the study results. This is a restrictive limitation given that ...

objectives the aim of this study was to study the incremental cost-effectiveness ratio associated with the use of heat and moisture exchangers (hme) filter to prevent vap compared with the heated humidifiers (hh) presently adopted by intensive care unit (icu) services within the brazilian healthcare unified system. patients and methods this study was a cost-effectiveness analysis (cea) comparin...

Cost-effectiveness analysis (CEA) is widely used to assess the investment criteria where cost-benefit analysis (CBA) is not economically feasible to apply. CBA is generally used where there is a commercial motive whereas CEA is used where service motive is prioritized. Thus, it is mainly applicable to evaluate social projects where the beneficiaries are scattered in any area or the society at l...

OBJECTIVE Before cost-effectiveness analysis (CEA) can fulfill its promise as a tool to guide health care allocation decisions, the method of incorporating societal values into CEA may need to be improved. DESIGN The study design was a declarative exposition of potential fallacies in the theoretical underpinnings of CEA. Two values held by many people-preferences for giving priority to severe...

This paper identifies and illustrates the challenges of conducting cost-effectiveness analysis (CEA) of addiction treatments given the multiple important outcomes of substance abuse treatment (SAT). Potential problems arise because CEA is intended primarily for single outcome programs, yet addiction treatment results in a variety of outcomes such as reduced drug use and crime and increased empl...

Introduction: This paper demonstrates that standard cost-effectiveness screening of pharmaceutical drugs may give misleading results if systematic data heterogeneity by base health related quality of life (BHRQoL), the HRQoL immediately prior to treatment, is ignored. Study Design: It is argued that for some chronic diseases, such as rheumatoid arthritis, the magnitude of the HRQoL response to ...

Chronic kidney disease (CKD) is a condition in which the kidneys are unable to maintain fluid balance of metabolic waste that progressive, irreversible, and takes place slowly. Anemia complication CKD contributes morbidity, mortality, quality life patients, as well greater costs care. This study aims evaluate differences effectiveness cost anemia therapy with epoetin patients chronic disease. T...